Acquired by CVS Health in May 2023
OSH - Oak Street Health, Inc.
NYSE
->
Healthcare
->
Medical Care Facilities
Chicago,
United States
Type: Equity
OSH price evolution
OSH
| (in millions $) | 31 Mar 2023 | 31 Jan 2023 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $156.2 | $137.9 | $223 | $136.8 |
| Short term investments | $226 | $287.7 | $339 | $429.5 |
| Net receivables | $1218.4 | $896.5 | $836 | $828.2 |
| Inventory | ||||
| Total current assets | $1621.4 | $1358.6 | $1416.1 | $1405.1 |
| Long term investments | ||||
| Property, plant & equipment | $526.5 | $521.7 | $509.2 | $487.8 |
| Goodwill & intangible assets | $166.7 | $167.1 | $167.6 | $162.7 |
| Total noncurrent assets | $700 | $696.1 | $684.4 | $658.1 |
| Total investments | $226 | $287.7 | $339 | $429.5 |
| Total assets | $2321.4 | $2054.7 | $2100.5 | $2063.2 |
| Current liabilities | ||||
| Accounts payable | $31.1 | $17.1 | $25.9 | $23.5 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $1203.1 | $963.1 | $906.5 | $897.2 |
| Long term debt | $1355.2 | $978.6 | $1318.8 | $1239.6 |
| Total noncurrent liabilities | $1385 | $1358.9 | $1349.6 | $1267.9 |
| Total debt | $1355.2 | $1327.9 | $1318.8 | $1239.6 |
| Total liabilities | $2588.1 | $2325.8 | $2256.1 | $2165.1 |
| Shareholders' equity | ||||
| Retained earnings | -$1520 | -$1474.5 | -$1341.5 | -$1210.8 |
| Other shareholder equity | -$0.8 | -$2.2 | -$4.1 | -$4.8 |
| Total shareholder equity | -$270.3 | -$271.1 | -$160.4 | -$106.9 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $137.9 | $120.4 | $419.73 | $42.25 |
| Short term investments | $287.7 | $671.1 | ||
| Net receivables | $896.5 | $562.5 | $256.5 | $168.16 |
| Inventory | ||||
| Total current assets | $1358.6 | $1368 | $687.18 | $219.82 |
| Long term investments | ||||
| Property, plant & equipment | $521.7 | $302.5 | $78.79 | $67.4 |
| Goodwill & intangible assets | $167.1 | $163.7 | $12.6 | $12.99 |
| Total noncurrent assets | $696.1 | $473.1 | $93.8 | $82 |
| Total investments | $287.7 | $671.1 | ||
| Total assets | $2054.7 | $1841.1 | $780.98 | $301.82 |
| Current liabilities | ||||
| Accounts payable | $17.1 | $22.1 | $8.82 | $10.76 |
| Deferred revenue | ||||
| Short long term debt | $18.51 | |||
| Total current liabilities | $963.1 | $664.1 | $315.49 | $239.5 |
| Long term debt | $978.6 | $1065.6 | $62.84 | |
| Total noncurrent liabilities | $1358.9 | $1121 | $42.27 | $86.56 |
| Total debt | $1327.9 | $1065.6 | $81.35 | |
| Total liabilities | $2325.8 | $1785.1 | $357.76 | $326.06 |
| Shareholders' equity | ||||
| Retained earnings | -$1474.5 | -$965.3 | -$555.84 | -$354.36 |
| Other shareholder equity | -$2.2 | -$1.4 | $7.04 | $9.48 |
| Total shareholder equity | -$271.1 | $51.4 | $416.18 | -$350.16 |
| (in millions $) | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $752 | $577.7 | $545.7 | $523.7 |
| Cost of revenue | $652.7 | $576.8 | $541 | $490.5 |
| Gross Profit | $99.3 | $0.9 | $4.7 | $33.2 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $132.2 | $123.3 | $125.8 | $137.5 |
| Total operating expenses | $142.7 | $133.2 | $134.9 | $145.9 |
| Operating income | -$43.4 | -$132.3 | -$130.2 | -$112.7 |
| Income from continuing operations | ||||
| EBIT | -$44.9 | -$131.4 | -$130.7 | -$148.6 |
| Income tax expense | $0.2 | |||
| Interest expense | $0.6 | $1.4 | $0.5 | |
| Net income | ||||
| Net income | -$45.5 | -$133 | -$130.7 | -$149.1 |
| Income (for common shares) | -$45.5 | -$133 | -$130.7 | -$149.1 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2160.9 | $1432.6 | $882.76 | $556.6 |
| Cost of revenue | $2082.8 | $1402.7 | $805.36 | $526.85 |
| Gross Profit | $78.1 | $29.9 | $77.41 | $29.75 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $509.1 | $426.1 | $249.71 | $125.78 |
| Total operating expenses | $544.3 | $443.9 | $260.93 | $133.63 |
| Operating income | -$466.2 | -$414 | -$183.52 | -$103.88 |
| Income from continuing operations | ||||
| EBIT | -$506.5 | -$408.8 | -$179.28 | -$102.21 |
| Income tax expense | $0.2 | -$1.9 | ||
| Interest expense | $2.5 | $2.5 | $8.71 | $5.65 |
| Net income | ||||
| Net income | -$509.2 | -$409.4 | -$187.99 | -$107.86 |
| Income (for common shares) | -$509.2 | -$409.4 | -$215.21 | -$137.23 |
| (in millions $) | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Net income | -$45.5 | -$133 | -$130.7 | -$149.1 |
| Operating activities | ||||
| Depreciation | $21 | $13.7 | $20.4 | $23.7 |
| Business acquisitions & disposals | -$1.5 | -$5.8 | $0.2 | |
| Stock-based compensation | $24.8 | $18.9 | $30.8 | $49.8 |
| Total cash flows from operations | -$92.7 | -$96.1 | -$33.9 | -$88.2 |
| Investing activities | ||||
| Capital expenditures | -$17 | -$21.6 | -$27.9 | -$19.9 |
| Investments | $63.9 | $53 | $90.3 | $120.1 |
| Total cash flows from investing | $46.9 | $29.9 | $56.6 | $100.4 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $20.1 | $1.3 | $13.4 | $0.1 |
| Net borrowings | $24.9 | $72.3 | ||
| Total cash flows from financing | $43.5 | $1.7 | $63.5 | -$0.7 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$2.3 | -$64.5 | $86.2 | $11.5 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$509.2 | -$409.4 | -$187.99 | -$107.86 |
| Operating activities | ||||
| Depreciation | $70.6 | $33.3 | $11.22 | $7.85 |
| Business acquisitions & disposals | -$7.1 | -$129 | -$0.17 | |
| Stock-based compensation | $138.9 | $161.4 | $77.43 | $3.73 |
| Total cash flows from operations | -$309.4 | -$197.2 | -$77.22 | -$55.55 |
| Investing activities | ||||
| Capital expenditures | -$89.2 | -$81.3 | -$20.88 | -$27.7 |
| Investments | $377.4 | -$677.1 | -$0.75 | |
| Total cash flows from investing | $281.1 | -$887.4 | -$21.63 | -$27.87 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $18.8 | $8.3 | $358.01 | |
| Net borrowings | $72.3 | $897.9 | -$85.78 | $49.46 |
| Total cash flows from financing | $66.4 | $785.3 | $476.32 | $53.6 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $38.1 | -$299.3 | $377.47 | -$29.81 |
News
|
CVS to close store in heart of Orlando's College Park neighborhood. Here's what's next.
American City Business Journals
26 Apr 2023
|
|
What You Can Learn From Oak Street Health, Inc.'s (NYSE:OSH) P/S
Simply Wall St. via Yahoo Finance
19 Apr 2023
|
|
Global dealmaking sinks to lowest level in over a decade By Reuters
Investing.com
31 Mar 2023
|
|
Global dealmaking sinks to lowest level in over a decade
MSN News
30 Mar 2023
|
|
3 Great Stocks to Buy and Hold Until You Retire | Entrepreneur
Entrpreneur
22 Mar 2023
|
|
U.S. Senator Warren urges FTC to review CVS-Oak Street deal
Reuters
22 Mar 2023
|
|
US Senator Warren urges FTC to review CVS-Oak Street deals - Bloomberg News
Reuters
21 Mar 2023
|
|
CVS Health: Oak Street Acquisition Is A Good Strategic Fit (NYSE:CVS)
Seeking Alpha
15 Mar 2023
|
|
Pfizer to Pay $43 Billion for Seagen, Set Post-Covid Course
Bloomberg via Yahoo Finance
13 Mar 2023
|
|
Factbox-Which companies are affected by SVB collapse?
Reuters via Yahoo Finance
12 Mar 2023
|
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $2.40B |
|---|---|
| EBITDA | -$376.80M |
| EBIT | -$455.60M |
| Net Income | -$458.30M |
| Revenue Q/Q | 46.36% |
| Revenue Y/Y | 45.43% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | -21.47% |
| ROE | 226.68% |
| Debt/Equity | -8.58 |
|---|---|
| Net debt/EBITDA | -6.45 |
| Current ratio | 1.35 |
| Quick ratio | 1.35 |